Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cochlear Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cochlear Limited (ASX: COH)
Latest News
⏸️ Investing
Buy these 3 shares for strong diversification
⏸️ Investing
Is this medical device stock the next to surge after Cochlear Limited and ResMed Inc.?
⏸️ Investing
How safe is your money in ResMed Inc. (CHESS) shares?
⏸️ Investing
Top broker says US tax cuts will drive double-digit earnings upgrades for these ASX stocks
⏸️ Investing
Revealed: The ASX's top performing sectors in 2017
⏸️ Investing
10 top shares for 2017 in review
⏸️ Investing
Is Speedcast International Ltd still a buy?
⏸️ Investing
Why CSL Limited looks like a buy at this share price
⏸️ Investing
5 top shares I'd buy for 2018 and beyond
⏸️ Investing
Has the ASX hit its peak?
⏸️ Investing
Cochlear Limited shares just hit an all-time high
⏸️ Investing
3 ASX tech losers I'd give a wide berth
Frequently Asked Questions
-
Yes, Cochlear Ltd has historically paid two fully franked dividends a year.
-
Cochlear Ltd generally pays its dividends in April and October.
-
Cochlear Ltd listed on the ASX on 4 December 1995.
COH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cochlear Limited
Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.
The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.
Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.
Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.
